-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: patents
USTR: TPP to have High IP Standards to “Stand Alongside other Treaty Agreements in the Area”
Stan McCoy, Assisant U.S. Trade Representative for Intellectual Property and Innovation, spoke at BIO’s 2011 Convention session titled The Trans-Pacific Partnership and the Importance of Intellectual Property Rights: Attracting Investment in Biotechnology. The session covered the ongoing treaty negotiations and the relevance of different IP provisions to the biotechnology industry. Issues of particular importance to the biotechnology industry yet to be revelead to the public include language tabled for data protection and patent linkage. While USTR specific language is not available, Read More >
Patents in the U.S. Supreme Court
A special session at the 2011 BIO International Convention takes a fascinating look at the underlying factors involved in the U.S. Supreme Court hearing patent cases. The Supreme Court has been accepting patent cases at a higher rate than ever before, with three major patent appeals reviewed this past term alone. And the Court seems poised to accept several more in the coming year. According to the session moderator, Chief Judge (Ret.) Paul Michel from Read More >
Blogging from #BIO2011
by Stephen Albainy-Jenei, from Patent Baristas You can keep up with what’s happening at BIO 2011 on BIOTechNOW (@BIOTechNOW) plus all the BIO Official Bloggers hitting the floor at the convention. I’ll be in attendance as well as participating in the BIO Official Blogger network throughout the week. If you’d like to meet up during the conference, drop me a note and we’ll schedule some time to have coffee together.
Docs at BIO: Patent Litigation Tactics and Strategies for Biosimilars
One of the highlights of the afternoon sessions at the BIO International Convention was a seminar appropriately entitled “A Brave New World: Patent Litigation Tactics and Strategies for Biosimilars,” where an experienced panel of patent attorneys presented their interpretation of the new biosimilars pathway of the Biologics Price Competition and Innovation Act and speculated on some of the potential issues that will arise once the statute is put into practice. From Patent Docs.
Patent backlog hinders nation’s job creation
Article from the Milwaukee Journal Sentinel with interesting numbers. Highlights: -Many of the missing jobs – hundres of thousands or possibly millions – are buried under the backlog of 1.2 million unprocessed patent applicatoins that have accumulated over the past 10 years at the U.S. Patent and Trademark Office. -A single U.S. patent can create three to ten jobs. -Nothaft estimates more than 2 million new jobs are buried in the backlog -”Innovation is our Read More >
